Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
EmbarkHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$94.55MSeries B7/26/2021$75M$759.47M$16.96SoftBank, F-Prime Capital, SV Angel, Slow Ventures, Freestyle Capital, Third Kind Venture Capital
Frontier MedicinesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$255.5MSeries C6/25/2024$100M$438.18M$2.34Deerfield Management Company, Droia Ventures, Galapagos NV, DCVC, MPM Capital, RA Capital Management, Deep Track Capital, ArrowMark Partners
GrailHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$2.02BSeries D5/6/2020$392.01M$4.26B$5.11Public Sector Pension Investment Board, Canada Pension Plan Investment Board, Illumina
LetsGetCheckedHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Orca BioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$541.19MSeries F1/9/2026$136.35M$2.4B$54.99Lightspeed Venture Partners
OriginHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Skyhawk TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Triveni BioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$297.49MSeries C6/17/2026$65.25M$423.44M$1.26Ascenta Capital, Janus Henderson Investors, Deep Track Capital, OrbiMed, Atlas Venture, Viking Global Investors
MedableHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$530.96MSeries D10/26/2021$304.88M$2.1B$9.67Blackstone Growth, Tiger Global, GSR Ventures, Sapphire Ventures, WTI
OSSIOHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Scribe TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$120.71MSeries B3/31/2021$100M$351.77M$35.83Avoro Ventures, Avoro Capital Advisors, OrbiMed, Andreessen Horowitz, Perceptive Advisors, T. Rowe Price, Wellington Management, RA Capital Management, Menlo Venture
SynthegoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$415.07MSeries E2/17/2022$144.17M$1.3B$10.78Perceptive Advisors, SoftBank, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund, Chimera Abu Dhabi, Wellington Management, RA Capital Management, Moore Strategic Ventures
Tessera TherapeuticsHealthcare
Biotech & Pharma
Low$xx.xx$xx.xx$xx.xxxx%--------Not available----$587.85MSeries D12/1/2025$200M$668.33M$5.18Bill & Melinda Gates Foundation, Regeneron
CG OncologyHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$510.76MSeries F8/2/2023$105.02M$615.24M$1.29Foresite Capital, TCGX, Avidity Partners, BVF Partners, Janus Henderson Investors, Acorn Bioventures, Ally Bridge Group, Decheng Capital, Longitude Capital, Malin Corporatoin, RA Capital Management
EvozyneHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$109.19MSeries B9/27/2023$50M$288.32M$15.49Fidelity Management & Research Company, OrbiMed, NVentures, Paragon Biosciences, Valor Equity Partners
FreenomeHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.35BSeries F2/15/2024$263.96M$2.05B$7.40Roche, Andreessen Horowitz, BrightEdge Ventures, ARK Investments, ArrowMark Partners, Artis Ventures, Bain Capital, Cormorant Capital, DCVC, Eventide Asset Management LLC, Intermountain Ventures, Perceptive Advisors, Polaris Partners, Pura Vida Investments, Quest Diagnostics, RA Capital Management, Sands Capital, Section 32, Squarepoint Capital, T. Rowe Price Associates
Neurona TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$342.29MSeries F4/3/2025$101.71M$578.63M$2.06Fidelity, The Column Group, Soleus Capital, Viking Global Investors, Cormorant Asset Management, Schroders Capital, LYFE Capital, Euclidean Capital, UCB Ventures, Willett Advisors, UC Investments, YK Bioventures, Berkeley Frontier Fund, Ysios Capital, Alexandria Venture Investments, Spur Capital Partners
Numerion LabsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$132.26MSeries D3/10/2026$19.79M$122.5M$0.37Undisclosed Investors
Timberlyne TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$9.88MSeries A1/9/2025$9.37M$137.37M$3.64Abingworth, Bain Capital Life Sciences, Venrock, Boyu Capital, Lilly Asia Ventures, Braidwell, 3H Health Investment
Vedanta BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$126.86MSeries B-18/6/2026$22.57M$113.87M$0.17AMR Action Fund, BNP Paribas
Alloy TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$176.24MSeries E-14/15/2026$30M$1B$26.178VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, Ulysses Diversified Holdings
Ampersand BiomedicinesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$109.61MSeries B3/19/2025$65M$360.94M$5.80Flagship Pioneering, Eli Lilly & Company
AQEMIAHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
ArsenalBioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$2.44BSeries C9/4/2024$327.5M$1.66B$18.58ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.